These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8035834

  • 1. Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern.
    Xu M, Capraro GA, Daibata M, Reyes VE, Humphreys RE.
    Mol Immunol; 1994 Jul; 31(10):723-31. PubMed ID: 8035834
    [Abstract] [Full Text] [Related]

  • 2. More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release.
    Daibata M, Xu M, Humphreys RE, Reyes VE.
    Mol Immunol; 1994 Mar; 31(4):255-60. PubMed ID: 8139580
    [Abstract] [Full Text] [Related]

  • 3. Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.
    Reyes VE, Lu S, Humphreys RE.
    J Immunol; 1991 Jun 01; 146(11):3877-80. PubMed ID: 2033257
    [Abstract] [Full Text] [Related]

  • 4. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
    Burster T, Macmillan H, Hou T, Schilling J, Truong P, Boehm BO, Zou F, Lau K, Strohman M, Schaffert S, Busch R, Mellins ED.
    Immunology; 2010 Jul 01; 130(3):436-46. PubMed ID: 20331476
    [Abstract] [Full Text] [Related]

  • 5. Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment.
    Demotz S, Danieli C.
    Mol Immunol; 1993 Dec 01; 30(18):1623-32. PubMed ID: 8272076
    [Abstract] [Full Text] [Related]

  • 6. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E, Cameron P, Amaya M, Goodman S, Pious D, Smith L, Arp B.
    J Exp Med; 1994 Feb 01; 179(2):541-9. PubMed ID: 8294865
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.
    Kropshofer H, Vogt AB, Hämmerling GJ.
    Proc Natl Acad Sci U S A; 1995 Aug 29; 92(18):8313-7. PubMed ID: 7667286
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X, Bavari S, Ulrich R, Sadegh-Nasseri S, Ferrone S, McHugh L, Mage M.
    Eur J Immunol; 1997 Aug 29; 27(8):1933-41. PubMed ID: 9295029
    [Abstract] [Full Text] [Related]

  • 11. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H, Brunet A, Thibodeau J.
    J Cell Sci; 2005 Oct 15; 118(Pt 20):4679-87. PubMed ID: 16188937
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Invariant chain dissociation from class II MHC is a catalyst for foreign peptide binding.
    Reyes VE, Daibata M, Espejo R, Humphreys RE.
    Ann N Y Acad Sci; 1994 Aug 15; 730():338-41. PubMed ID: 8080205
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of brefeldin A on cleavage of invariant chain to p21 and p10 and the appearance of Ii-freed class II MHC dimers.
    Nguyen QV, Roskey AM, Humphreys RE.
    Mol Immunol; 1993 Feb 15; 30(2):137-44. PubMed ID: 8429832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA, Cresswell P.
    J Immunol; 1992 Jun 01; 148(11):3478-82. PubMed ID: 1588042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.